Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | 30,000 | reported | 17 Jun 2024 | tx 6+108,999 |
| Senti Biosciences, Inc. | 21,950 | reported | 25 Jun 2025 | tx 5+315,850 |
| Orion Biotech Opportunities Corp. | 0 | reported | 17 May 2023 | tx 1−40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jun 2025 | GRANT_AWARD | Senti Biosciences, Inc. | 21,950 | 0.00 USD | deriv |
| 07 Mar 2025 | GRANT_AWARD | Senti Biosciences, Inc. | 43,900 | 0.00 USD | deriv |
| 10 Jul 2024 | GRANT_AWARD | Senti Biosciences, Inc. | 62,500 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 27 Jun 2023 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Senti Biosciences, Inc. | 62,500 | 0.00 USD | deriv |
| 17 May 2023 | OTHER | Orion Biotech Opportunities Corp. | 40,000 | 0.00 USD | deriv |
| 13 Jul 2022 | GRANT_AWARD | Senti Biosciences, Inc. | 125,000 | 0.00 USD | deriv |
| 27 Jun 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 11 Jun 2020 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 9,285 | 0.00 USD | deriv |
| 18 Jul 2019 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 5,714 | 0.00 USD | deriv |